BioHealth News Archive
Novavax Statement on Proof of COVID-19 Vaccine Requirements for PREVENT-19 Clinical Trial Participants in the U.S.
The U.S. Centers for Disease Control and Prevention (CDC) recently provided updated guidance stating that participants in the Novavax PREVENT-19 Phase 3 clinical trial meet the…
Read MoreHemoShear Therapeutics (PRNewsfoto/HemoShear Therapeutics) | | johnsoncitypress.com
CHARLOTTESVILLE, Va., Sept. 21, 2021 /PRNewswire/ -- HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has earned a milestone payment for the advancement…
Read MoreBioTalk: From the 7th Annual BioHealth Capital Region Forum – Dr. Anthony Fauci
Listen to the audio as Rich Bendis, President and CEO of BioHealth Innovation conducts a fireside chat with Dr. Anthony Fauci, Director of the…
Read MoreViewpoint: Ready for an HQ2 redux? It’s time to come together for new regional tech collaboration.
Remember the frenzy in 2017 when over 200 cities and towns across the U.S. bid to house the second headquarters for Amazon? Northern Virginia…
Read MorePatient-Centric Approach to Clinical Trials Improves Outcomes for All Stakeholders
According to researchers at the MIT Sloan School of Management, the probability of FDA approval of an industry-sponsored drug entering Phase One of the…
Read MoreVCs make record bets on quantum computing | PitchBook
Scientists and engineers are still toiling in labs in a race to develop quantum computers that would significantly outperform traditional computers. But that isn't…
Read MoreIs a variant worse than Delta on the way? Viral evolution offers clues.
Somewhere in India last October, a person—likely immunocompromised, perhaps taking drugs for rheumatoid arthritis or with an advanced case of HIV/AIDS—developed COVID-19. Their case…
Read MoreVisualizing the World’s Biggest Pharmaceutical Companies
If the response to the COVID-19 pandemic has taught us anything, it is that in building a patient-centered future, the pharmaceutical industry plays a…
Read MoreOpinion: President Biden: Don’t misuse Bayh-Dole march-in rights – Med-stat.info
In a misguided attempt to control drug costs, some Congressional leaders are urging the Biden administration to misapply a 40-year-old law that supports 6…
Read MoreAmerican Gene Technologies Appoints Dr. Robert R. Redfield as Special Advisor to the CEO | American Gene Technologies
American Gene Technologies (AGT) announces the appointment of Dr. Robert R. Redfield, former director of the Centers for Disease Control and Prevention (CDC) and…
Read More7th Annual Virtual BioHealth Capital Region Forum Recap
The 7th Annual Virtual BioHealth Capital Region Forum might be over, but that doesn’t mean you can’t access it again. Go to https://eventmobi.com/bhcrforum2021 now to watch…
Read More5 Questions with Bill Snider, Partner, BroadOak Capital Partners · BioBuzz
“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little…
Read MoreRobert E. Fischell Institute for Biomedical Devices Director William Bentley was named the recipient of the 2021 Society for Biological Engineering D.I.C. Wang Award for Excellence in Biochemical Engineering.
Robert E. Fischell Institute for Biomedical Devices Director William Bentley was named the recipient of the 2021 Society for Biological Engineering D.I.C. Wang Award for Excellence…
Read MoreGain Therapeutics, Inc. Announces Positive Topline Data in
BETHESDA, Md., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying and…
Read MoreMaryland Today | IonQ, UMD to Establish First-of-its-Kind Facility to…
IonQ, the leading developer of quantum computing devices, and the University of Maryland, an international powerhouse in quantum research and applications, today announced a…
Read More